Top Markets
#1 Status Status +19.34%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +14.26%
#4 Ontology Gas Ontology Gas +12.27%
#5 DMT-NAT DMT-NAT +8.99%
#6 Nillion Nillion +7.04%
#7 Provenance Blockchain Provenance Blockchain +7.02%
#8 Janction Janction +6.49%
#9 Cap Cap +6.34%
#10 Bedrock Bedrock +5.75%
Coin of the day
Status Status
Настройки
Язык
Pусский
Валюта
USD
Тема
Cadrenal Therapeutics, Inc. Common Stock Cadrenal Therapeutics, Inc. Common Stock

Cadrenal Therapeutics, Inc. Common Stock

CVKD
Ранг среди акций #33959
Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise... Cadrenal Therapeutics, Inc. operates as a biopharmaceutical enterprise primarily engaged in clinical development. The company's core focus is the advancement of Tecarfarin, a novel therapeutic agent that has received orphan drug designation. This treatment is engineered to prevent systemic thromboembolism originating from cardiac issues in patients suffering from both end-stage renal disease and atrial fibrillation. Established in 2022, the firm is headquartered in Ponte Vedra, Florida.
Цена акции
$1.83
Последняя синхронизация: 2026-08-14
Рыночная капитализация
$6.53M
Изменение (1 день)
-1.61%
Изменение (1 год)
-85.57%
Страна
US
Торговля Cadrenal Therapeutics, Inc. Common Stock (CVKD)

Категория

Healthcare
История цены акций Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Наивысшая цена закрытия: $1.89 2026-08-01

Наименьшая цена закрытия: $46.78 2023-01-01
История цены акций Cadrenal Therapeutics, Inc. Common Stock с 2023 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -11.31%
2025 -35.19%
2024 69.00%
2023 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE